These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14973354)

  • 1. Angiotensin-converting enzyme inhibitors are not effective at inhibiting further fibrous changes in the atria in patients with chronic atrial fibrillation: speculation from analysis of the time course of fibrillary wave amplitudes.
    Hirayama Y; Atarashi H; Kobayashi Y; Takano T
    Jpn Heart J; 2004 Jan; 45(1):93-101. PubMed ID: 14973354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term follow-up of the f wave amplitude in chronic atrial fibrillation].
    Saitho H; Atarashi H; Fujiwara T; Hayakawa H
    Nihon Ronen Igakkai Zasshi; 1989 Sep; 26(5):489-93. PubMed ID: 2614999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE-inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation.
    Boldt A; Scholl A; Garbade J; Resetar ME; Mohr FW; Gummert JF; Dhein S
    Basic Res Cardiol; 2006 May; 101(3):261-7. PubMed ID: 16382287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic importance of fibrillatory wave amplitude: a clue to echocardiographic left atrial size and etiology of atrial fibrillation.
    Aysha MH; Hassan AS
    J Electrocardiol; 1988 Aug; 21(3):247-51. PubMed ID: 2971749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of angiotensin converting enzyme inhibitor on the expression of angiotensin converting enzyme 2 in atrium of patients with atrial fibrillation].
    Hu XS; Xie XD; Wang XX; Zeng CL; Ni YM; Yu GW; Chen JZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):625-8. PubMed ID: 17961427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.
    Coleman CI; Makanji S; Kluger J; White CM
    Ann Pharmacother; 2007 Mar; 41(3):433-7. PubMed ID: 17341525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive prediction of catheter ablation outcome in persistent atrial fibrillation by fibrillatory wave amplitude computation in multiple electrocardiogram leads.
    Zarzoso V; Latcu DG; Hidalgo-Muñoz AR; Meo M; Meste O; Popescu I; Saoudi N
    Arch Cardiovasc Dis; 2016 Dec; 109(12):679-688. PubMed ID: 27402153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of fibrillatory wave amplitude. A clue to left atrial appendage function in nonrheumatic atrial fibrillation.
    Li YH; Hwang JJ; Tseng YZ; Kuan P; Lien WP
    Chest; 1995 Aug; 108(2):359-63. PubMed ID: 7634867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
    Lévy S
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):220-5. PubMed ID: 16568131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive effect of renin-angiotensin system inhibitor on left atrial remodelling in patients with chronic atrial fibrillation: long-term echocardiographic study.
    Fukuda Y; Fukuda N; Morishita S; Tamura Y
    Eur J Echocardiogr; 2011 Apr; 12(4):278-82. PubMed ID: 21266378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment of permanent atrial fibrillation and time course of the amplitude of the f wave].
    Sakamoto H; Imataka K; Naitoh S; Nishimura H; Seko Y; Fujii J
    Nihon Ronen Igakkai Zasshi; 1990 Nov; 27(6):687-92. PubMed ID: 2079753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrillatory wave amplitude as a marker of left atrial and left atrial appendage function, and a predictor of thromboembolic risk in patients with rheumatic mitral stenosis.
    Mutlu B; Karabulut M; Eroglu E; Tigen K; Bayrak F; Fotbolcu H; Basaran Y
    Int J Cardiol; 2003 Oct; 91(2-3):179-86. PubMed ID: 14559128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation and renin-angiotensin system.
    Serra JL; Bendersky M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure.
    Shi Y; Li D; Tardif JC; Nattel S
    Cardiovasc Res; 2002 May; 54(2):456-61. PubMed ID: 12062350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of frequency of thromboembolic events and echocardiographic findings in patients with chronic nonvalvular atrial fibrillation and coarse versus fine electrocardiographic fibrillatory waves.
    Yamamoto S; Suwa M; Ito T; Murakami S; Umeda T; Tokaji Y; Sakai Y; Kitaura Y
    Am J Cardiol; 2005 Aug; 96(3):408-11. PubMed ID: 16054469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage flow in nonrheumatic atrial fibrillation : relationship with pulmonary venous flow and ECG fibrillatory wave amplitude.
    Bollmann A; Binias K; Grothues F; Sonne K; Esperer H; Nikutta P; Klein H
    Chest; 2001 Feb; 119(2):485-92. PubMed ID: 11171727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on risk of atrial fibrillation before coronary artery bypass grafting.
    Johnston K; Stephens S
    Ann Pharmacother; 2012 Sep; 46(9):1239-44. PubMed ID: 22947592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling.
    Liu E; Xu Z; Li J; Yang S; Yang W; Li G
    Int J Cardiol; 2011 Feb; 146(3):364-70. PubMed ID: 19732978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathophysiology of the renin-angiotensin-system in atrial fibrillation].
    Heusch G; Schulz R
    Dtsch Med Wochenschr; 2006 Apr; 131(15):817-20. PubMed ID: 16607602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation.
    Goette A; Staack T; Röcken C; Arndt M; Geller JC; Huth C; Ansorge S; Klein HU; Lendeckel U
    J Am Coll Cardiol; 2000 May; 35(6):1669-77. PubMed ID: 10807475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.